Malabsorption as a Cause of Iron Treatment Failure in Infants

Malabsorption as a Cause of Iron Treatment Failure in Infants - A Clinical Observational Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00456729

Enrollment

100

Registered

2007-04-05

Start date

2006-05-31

Completion date

2006-07-31

Last updated

2007-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Deficiency, Malabsorption

Keywords

Iron deficiency, Malabsorption, Giardiasis

Brief summary

Infants should receive prophylacatic iron supplementation since age 4 months till one year. Patients suffering from malabsorption, mainly Giardia infestation may develop iron deficiency resistent to further iron treatment. The purpose of this study is to assess the incidence of malabsorption in those infants and to examine the results of empiric treatment with metronidazole.

Interventions

DRUGMetronidazole

PROCEDUREBlood tests

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

6 Months to 4 Years

Healthy volunteers

Inclusion criteria

* All infants referred to the Pediatric Hematology Unit because lack of response to iron treatment.

Exclusion criteria

* Patients diagnosed with specific malabsorption causes like Celiac or Cystic Fibrosis.

Design outcomes

Primary

Measure	Time frame
Hgb level	—

Secondary

Measure	Time frame
Iron level	—
Ferritin Level	—

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026